WR Wealth Planners LLC Sells 317 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

WR Wealth Planners LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,315 shares of the healthcare conglomerate’s stock after selling 317 shares during the quarter. WR Wealth Planners LLC’s holdings in UnitedHealth Group were worth $1,171,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. DecisionPoint Financial LLC lifted its position in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $57,000. Finally, FPC Investment Advisory Inc. lifted its position in shares of UnitedHealth Group by 863.6% in the 4th quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after purchasing an additional 95 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $474.95 on Friday. The company has a 50 day moving average price of $516.59 and a 200-day moving average price of $557.16. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $437.09 billion, a PE ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm posted $5.83 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.